Diagnostics-As-A-Service Market Report 2026

Diagnostics-As-A-Service Market Overview

• Diagnostics-As-A-Service market size has reached to $5.4 billion in 2025 • Expected to grow to $13.88 billion in 2030 at a compound annual growth rate (CAGR) of 20.7% • Growth Driver: Increasing Prevalence Of Chronic Diseases Fueling The Growth Of The Market Due To Rising Need For Continuous Monitoring And Accessible Care • Market Trend: Kivra Acquires Truid To Strengthen Digital Identity And Health ID Wallet Capabilities • North America was the largest region in 2025.

What Is Covered Under Diagnostics-As-A-Service Market?

Diagnostics-as-a-service is a cloud-based healthcare model that delivers diagnostic testing, analysis, and reporting through digital platforms, often leveraging artificial intelligence (AI), internet of things (IoT), and remote connectivity. It helps to provide scalable, cost-effective, and accessible diagnostic solutions without the need for extensive in-house infrastructure. It enables real-time health monitoring, faster decision-making, and improved patient outcomes by streamlining diagnostic delivery across healthcare settings. The main components of diagnostics-as-a-service are software, services, and hardware. Software refers to cloud-based platforms that provide on-demand diagnostic testing, analysis, and reporting, enabling scalable, cost-effective, and accessible healthcare diagnostics. It can be deployed through cloud-based, on-premises, and hybrid modes. Its applications span clinical diagnostics, imaging, pathology, genomics, and others, and is widely used by hospitals and clinics, diagnostic laboratories, research institutes, and others.

What Is The Diagnostics-As-A-Service Market Growth Forecast?

The diagnostics-as-a-service market size is expected to see exponential growth in the next few years. It will grow to $13.88 billion in 2030 at a compound annual growth rate (CAGR) of 20.7%. The growth in the forecast period can be attributed to growing demand for real-time diagnostics, rising investments in ai-powered clinical decision support, expansion of remote patient monitoring, increasing focus on decentralized healthcare delivery, broader adoption of diagnostics-as-a-service models. Major trends in the forecast period include expansion of cloud-based diagnostic platforms, rising adoption of remote diagnostic services, increased integration of AI-based diagnostic tools, growing demand for scalable diagnostic infrastructure, enhanced focus on interoperable diagnostic systems.

Global Diagnostics-As-A-Service Market Segmentation

1) By Component: Software, Services, Platforms 2) By Deployment Mode: Cloud-Based, On-Premises, Hybrid 3) By Application: Clinical Diagnostics, Imaging Diagnostics, Pathology, Genomics, Other Applications 4) By End-User: Hospitals And Clinics, Diagnostic Laboratories, Research Institutes, Other End-Users Subsegments: 1) By Software: Diagnostic Analytics Software, Clinical Decision Support Software, Artificial Intelligence (AI) Or Machine Learning (ML)-Based Diagnostic Tools, Imaging And Visualization Software, Data Integration And Interoperability Software, Remote Monitoring And Reporting Software 2) By Services: Diagnostic Testing Services, Remote And Virtual Diagnostic Services, Cloud-Based Data Storage And Management, Consulting And Implementation Services, Training And Support Services, Maintenance And Upgradation Services 3) By Platforms: Cloud-based Diagnostic Platforms, On-Premise Diagnostic Platforms, Hybrid Deployment Platforms, Application Programming Interface (API) And Integration Platforms, Mobile Or Tele-Diagnostics Platforms, Data Exchange And Collaboration Platforms

What Is The Driver Of The Diagnostics-As-A-Service Market?

The increasing prevalence of chronic diseases is expected to propel the growth of the diagnostics-as-a-service market going forward. Chronic diseases are persistent health conditions that develop slowly and last for an extended period, often requiring continuous medical care. The growing prevalence of chronic diseases is partly due to inactive lifestyles, as prolonged sitting and minimal physical activity raise the risk of diseases such as heart conditions and diabetes. Diagnostics-as-a-service aids in chronic disease diagnosis by enabling cloud-based testing and analysis, making it easier to monitor long-term conditions. They improve care by offering timely insights, reducing hospital visits, and enhancing accessibility for patients with ongoing health needs. For instance, in June 2024, according to the National Health Service, a UK-based government department, 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes (a condition with elevated blood sugar levels, not high enough to be classified as diabetes) in 2023, marking an 18% increase from 3,065,825 cases in 2022. Therefore, the increasing prevalence of chronic diseases is driving the growth of the diagnostics-as-a-service industry.

Key Players In The Global Diagnostics-As-A-Service Market

Major companies operating in the diagnostics-as-a-service market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Koninklijke Philips N.V., GE Healthcare Technologies Inc., Becton Dickinson and Company, Agilent Technologies Inc., Hologic Inc., Bio-Rad Laboratories Inc., Guardant Health Inc., Invitae Corporation, InHealth Group Limited, Canon Medical Systems Corporation, Freenome Holdings Inc., BioSerenity SAS, PathAI Inc., Butterfly Network Inc., Aidoc Medical Ltd., Owkin Inc., K Health Inc.

Global Diagnostics-As-A-Service Market Trends and Insights

Major companies operating in the diagnostics-as-a-service market are focusing on developing patient-centric solutions, such as at-home lab testing services, to improve accessibility and convenience. At-home lab testing services are diagnostic kits that let people collect samples at home and get test results without visiting a clinic. For instance, in June 2025, Amazon India, a US-based e-commerce company, partnered with Orange Health Labs, an India-based healthcare company, and launched Amazon Diagnostics, an at-home lab testing service under Amazon Medical. It is available across six major cities and offers doorstep sample collection within 60 minutes and digital reports in as little as six hours, covering over 800 diagnostic tests. It allows customers to book, track, and access secure reports seamlessly by being integrated into the Amazon app. This initiative addresses key gaps in India’s diagnostic landscape delays, accessibility, and quality while strengthening Amazon’s vision of providing end-to-end healthcare services, including pharmacy and clinics.

What Are Latest Mergers And Acquisitions In The Diagnostics-As-A-Service Market?

In August 2024, Quest Diagnostics, a U.S.-based provider of diagnostic information services and clinical laboratory testing, acquired LifeLabs for an undisclosed amount. With this acquisition, Quest Diagnostics aimed to expand its diagnostics as a service footprint across North America by combining its specialized lab services and advanced testing capabilities with LifeLabs’ community-based laboratory network and digital-health infrastructure. LifeLabs is a Canada-based provider of community laboratory diagnostic services and digital-health connectivity systems.

Regional Outlook

North America was the largest region in the diagnostics-as-a-service market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Diagnostics-As-A-Service Market?

The diagnostics-as-a-service market includes revenues earned by entities through remote diagnostic testing, laboratory analysis, sample collection and processing, cloud-based reporting, and teleconsultation for test interpretation. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Diagnostics-As-A-Service Market Report 2026?

The diagnostics-as-a-service market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the diagnostics-as-a-service industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.